Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 01 Mar 2024 07:05 CET |
BPOST | bpost: fourth quarter 2023 results | 50206040 Delivery Services | Commercial results |
| 01 Mar 2024 07:04 CET |
BPOST | bpost: fourth quarter 2023 results | 50206040 Delivery Services | Commercial results |
| 01 Mar 2024 07:04 CET |
BPOST | bpost: fourth quarter 2023 results | 50206040 Delivery Services | Commercial results |
| 01 Mar 2024 07:00 CET |
BEKAERT | Bekaert: Résultats annuels 2023 | 55102010 Iron and Steel | Sales |
| 01 Mar 2024 07:00 CET |
BEKAERT | Bekaert: Jaarresultaten 2023 | 55102010 Iron and Steel | Sales |
| 01 Mar 2024 07:00 CET |
BEKAERT | Bekaert: 2023 Full Year Results | 55102010 Iron and Steel | Sales |
| 29 Feb 2024 22:30 CET |
NYXOAH SA | Nyxoah Participera à la 34ème Oppenheimer Annual Healthcare MedTech & Services Conference | 20102010 Medical Equipment | Other subject |
| 29 Feb 2024 22:30 CET |
NYXOAH SA | Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference | 20102010 Medical Equipment | Other subject |
| 29 Feb 2024 18:16 CET |
BELYSSE GROUP NV | James Neuling appointed CEO of Belysse Group NV | 40202015 Household Furnishings | Other subject |
| 29 Feb 2024 18:15 CET |
BELYSSE GROUP NV | James Neuling benoemd tot CEO van Belysse Group NV | 40202015 Household Furnishings | Other subject |
| 29 Feb 2024 18:00 CET |
FLUXYS BELGIUM | Accord entre Fluxys Belgium et la CREG sur la marge équitable | 60101035 Pipelines | Products and services |
| 29 Feb 2024 18:00 CET |
FLUXYS BELGIUM | Overeenkomst tussen Fluxys Belgium en de CREG over de billijke winstmarge | 60101035 Pipelines | Products and services |
| 29 Feb 2024 18:00 CET |
FLUXYS BELGIUM | Agreement between Fluxys Belgium and the CREG on the fair margin | 60101035 Pipelines | Products and services |
| 29 Feb 2024 11:42 CET |
MITHRA | DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase | 20103015 Pharmaceuticals | - |
| 29 Feb 2024 09:09 CET |
SHURGARD | 20240229 SHUR Full Year 2023 results February 29 2024 | 35101010 Real Estate Holding and Development | Commercial results |
| 29 Feb 2024 08:00 CET |
VAN DE VELDE | VAN DE VELDE : résultats annuels 2023 | 40204020 Clothing and Accessories | Commercial results |
| 29 Feb 2024 08:00 CET |
VAN DE VELDE | VAN DE VELDE : jaarresultaten 2023 | 40204020 Clothing and Accessories | Commercial results |
| 29 Feb 2024 08:00 CET |
VAN DE VELDE | VAN DE VELDE : year results 2023 | 40204020 Clothing and Accessories | Commercial results |
| 29 Feb 2024 07:45 CET |
GIMV | Share buyback finalised | 30202010 Asset Managers and Custodians | Other subject |
| 29 Feb 2024 07:45 CET |
AGFA-GEVAERT | Agfa advances sustainable innovation through strategic collaboration with VITO and EU funding for green hydrogen production | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 29 Feb 2024 07:45 CET |
GIMV | Share buyback finalised | 30202010 Asset Managers and Custodians | Other subject |
| 29 Feb 2024 07:45 CET |
AGFA-GEVAERT | Agfa bevordert duurzame innovatie door strategische samenwerking met VITO en EU-financiering voor groene waterstofproductie | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 29 Feb 2024 07:45 CET |
GIMV | Inkoop eigen aandelen afgerond | 30202010 Asset Managers and Custodians | Other subject |
| 29 Feb 2024 07:41 CET |
ONWARD MEDICAL | ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA | 20101025 Health Services | - |
| 29 Feb 2024 07:00 CET |
BIOSENIC | BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions | 20103010 Biotechnology | Legal |
| 29 Feb 2024 07:00 CET |
ARGENX SE | argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update | 20103010 Biotechnology | Other subject |
| 29 Feb 2024 07:00 CET |
ION BEAM APPLICATIONS | IBA signs contract with IAEA for the installation of a Cyclone® KEY in Benin, West Africa | 20102010 Medical Equipment | News contracts |
| 29 Feb 2024 07:00 CET |
ACKERMANS V.HAAREN | Ackermans & van Haaren realiseerde een nettowinst van 399,2 miljoen euro dankzij de recordprestaties van haar kernparticipaties | 30202000 Diversified Financial Services | Income |
| 29 Feb 2024 07:00 CET |
ACKERMANS V.HAAREN | Ackermans & van Haaren realised a net profit of 399.2 million euros, thanks to a record performance of its core participations | 30202000 Diversified Financial Services | Income |
| 29 Feb 2024 07:00 CET |
BIOSENIC | BioSenic S.A. : Information on the total number of voting rights and shares | 20103010 Biotechnology | Legal |
| 29 Feb 2024 07:00 CET |
ION BEAM APPLICATIONS | IBA signe un contrat avec l’AIEA pour l'installation d'un Cyclone® KEY au Bénin, en Afrique de l'Ouest | 20102010 Medical Equipment | News contracts |
| 29 Feb 2024 07:00 CET |
ACKERMANS V.HAAREN | Ackermans & van Haaren a réalisé un bénéfice net de 399,2 millions d’euros, grâce aux performances record de ses participations principales | 30202000 Diversified Financial Services | Income |
| 29 Feb 2024 06:59 CET |
RECTICEL | Recticel Annual Results 2023 | 50203015 Plastics | Other subject |
| 29 Feb 2024 06:59 CET |
RECTICEL | Recticel Jaarresultaten 2023 | 50203015 Plastics | Other subject |
| 28 Feb 2024 18:30 CET |
UMICORE | Umicore - Transparency notification by BlackRock, Inc. | 55201020 Specialty Chemicals | Other subject |
| 28 Feb 2024 18:30 CET |
UMICORE | Umicore - Déclaration de transparence par BlackRock, Inc. | 55201020 Specialty Chemicals | Other subject |
| 28 Feb 2024 18:30 CET |
UMICORE | Umicore - Transparantieverklaring van BlackRock, Inc. | 55201020 Specialty Chemicals | Other subject |
| 28 Feb 2024 14:00 CET |
AGEAS | Ageas SA/NV confirms possible offer for Direct Line Insurance Group Plc (Une version FR suivra) | 30301010 Life Insurance | Other financial transaction |
| 28 Feb 2024 14:00 CET |
AGEAS | Ageas SA/NV confirms possible offer for Direct Line Insurance Group Plc (een Nederlandse versie volgt later) | 30301010 Life Insurance | Other financial transaction |
| 28 Feb 2024 14:00 CET |
AGEAS | Ageas SA/NV confirms possible offer for Direct Line Insurance Group Plc | 30301010 Life Insurance | Other financial transaction |
| 28 Feb 2024 08:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: Agenda special general meeting 29.03.2024 | 35102030 Office REITs | General meeting / Board Meeting |
| 28 Feb 2024 08:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: Agenda special general meeting 29.03.2024 | 35102030 Office REITs | General meeting / Board Meeting |
| 28 Feb 2024 08:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: Agenda special general meeting 29.03.2024 | 35102030 Office REITs | General meeting / Board Meeting |
| 28 Feb 2024 07:30 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: results of IAP of takeover bid by TPG and reopening of the Offer on 28 February 2024 | 35102030 Office REITs | Change in Capital |
| 28 Feb 2024 07:30 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: results of IAP of takeover bid by TPG and reopening of the Offer on 28 February 2024 | 35102030 Office REITs | Change in Capital |
| 28 Feb 2024 07:30 CET |
AGEAS | Ageas publie ses résultats pour l’exercice 2023 | 30301010 Life Insurance | Other financial transaction |
| 28 Feb 2024 07:30 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: results of IAP of takeover bid by TPG and reopening of the Offer on 28 February 2024 | 35102030 Office REITs | Change in Capital |
| 28 Feb 2024 07:30 CET |
AGEAS | Ageas rapporteert resultaten voor 2023 | 30301010 Life Insurance | Other financial transaction |
| 28 Feb 2024 07:30 CET |
AGEAS | Ageas reports full-year results 2023 | 30301010 Life Insurance | Other financial transaction |
| 27 Feb 2024 18:00 CET |
VAN DE VELDE | VAN DE VELDE : inkoop eigen aandelen | 40204020 Clothing and Accessories | Other subject |